Chlorpromazine/Pentamidine

氯丙嗪/喷他脒

Report date: 2022/01/14 13:23:58

Base Information

Drug NameChlorpromazine/Pentamidine
Drug Alias NamePentamidine and Chlorpromazine喷他脒/氯丙嗪氯丙嗪+喷他脒Chlorpromazine and Pentamidine氯丙嗪喷他脒 +[9] 
ClassificationSmall molecules
Mechanisms of ActionDopamine receptors antagonistsKinesin-like protein 1 inhibitors
TargetsKinesin-like protein 1Dopamine receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Chlorpromazine HydrochloridePentamidine Isethionate
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZalicus Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZalicus Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A